UnitedHealth Group Incorporated
HealthcareNYSE:UNH · New York Stock Exchange
+$2.38 today
Vol 3.74M · Avg 8.25M
Income Statement
Follow revenue through to earnings
Review sales, margins, expenses, and profit trends to see what is actually driving reported earnings over time.
Earnings Waterfall
Revenue to Net Income
Key Ratios
Analysis
$449.7B of revenue converted into $12.0B of net income for the selected period. Gross margin is 18.8% and net margin is 2.7%, showing how much revenue survives after costs and taxes. EPS is $13.24, tying the income statement back to per-share earnings.
Income Statement
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $447.6B +11.8% | $400.3B +7.7% | $371.6B +14.6% | $324.2B +12.7% | $287.6B | $809.6M | $921.6M | $731.2M |
| Cost of Revenue | $364.6B +17.3% | $310.9B +10.8% | $280.7B +14.8% | $244.5B +12.2% | $217.9B | $725.6M | $804.0M | $882.4M |
| Gross Profit | $82.9B -7.3% | $89.4B -1.7% | $91.0B +14.2% | $79.6B +14.3% | $69.7B | $8.9B | $7.6B | $6.2B |
| Gross Margin | 18.5% -3.8pp | 22.3% -2.1pp | 24.5% -0.1pp | 24.6% +0.3pp | 24.2% | 9.8% | 28.9% | 38.3% |
| Research & Development | $0 | $0 | $0 | $0 | $0 | $983.2M | $1.3B | $490.4M |
| Selling, General & Admin | $0 | $0 | $0 | $0 | $0 | $620.6M | $923.0M | -$1.5B |
| Operating Expenses | $64.0B +12.0% | $57.1B -2.5% | $58.6B +14.5% | $51.2B +12.0% | $45.7B | $5.3B | $7.0B | $8.7B |
| Depreciation & Amortization | $4.4B +6.4% | $4.1B +3.2% | $4.0B +16.8% | $3.4B +9.6% | $3.1B | $374.2M | $1.2B | $631.8M |
| EBITDA | $23.1B -17.9% | $28.1B -22.7% | $36.3B +14.1% | $31.8B +17.6% | $27.1B | -$15.2B | $6.8B | $9.3B |
| EBITDA Margin | 5.2% -1.9pp | 7.0% -2.8pp | 9.8% -0.0pp | 9.8% +0.4pp | 9.4% | 5.6% | 46.3% | 42.0% |
| Operating Income | $19.0B -41.3% | $32.3B -0.2% | $32.4B +13.8% | $28.4B +18.6% | $24.0B | $12.3B | $14.0B | -$15.7B |
| Operating Margin | 4.2% -3.8pp | 8.1% -0.6pp | 8.7% -0.1pp | 8.8% +0.4pp | 8.3% | 16.6% | 24.1% | 22.0% |
| Interest Income | $0 | $0 | $0 | $0 | $0 | -$1.5B | -$1.6B | $405.0M |
| Interest Expense | $4.0B +2.5% | $3.9B +20.3% | $3.2B +55.2% | $2.1B +26.0% | $1.7B | $1.1B | $1.0B | $1.2B |
| Other Income / Expenses | -$4.3B +65.1% | -$12.2B -276.3% | -$3.2B -55.2% | -$2.1B -26.0% | -$1.7B | -$1.5B | $1.4B | $1.2B |
| Income Before Tax | $14.7B -26.8% | $20.1B -31.1% | $29.1B +10.5% | $26.3B +18.1% | $22.3B | $3.3B | $4.9B | $3.6B |
| Pre-Tax Margin | 3.3% -1.7pp | 5.0% -2.8pp | 7.8% -0.3pp | 8.1% +0.4pp | 7.8% | 20.8% | 18.7% | 26.2% |
| Income Tax Expense | $1.9B -60.9% | $4.8B -19.1% | $6.0B +4.6% | $5.7B +24.6% | $4.6B | $1.3B | -$1.6B | $745.2M |
| Net Income | $12.1B -16.3% | $14.4B -35.6% | $22.4B +11.2% | $20.1B +16.4% | $17.3B | $4.9B | $4.8B | $4.7B |
| Net Margin | 2.7% -0.9pp | 3.6% -2.4pp | 6.0% -0.2pp | 6.2% +0.2pp | 6.0% | 12.4% | 17.5% | 22.5% |
| EPS (Basic) | $13 -15.4% | $16 -35.2% | $24 +12.0% | $22 +17.5% | $18 | $400.8M | $703.2M | $1.3B |
| EPS (Diluted) | $13 -14.7% | $16 -35.0% | $24 +12.7% | $21 +17.1% | $18 | $766.2M | $609.4M | $452.6M |
| Weighted Avg Shares | $910.0M -2.0% | $929.0M +0.1% | $928.0M -0.6% | $934.0M -1.0% | $943.0M | $757.8M | $925.8M | $1.1B |
| Weighted Avg Shares (Diluted) | $910.0M -2.0% | $929.0M -1.0% | $938.0M -1.3% | $950.0M -0.6% | $956.0M | $1.2B | $924.4M | $678.0M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
Merck & Co., Inc.
NYSE:MRK
$296.38B
Novartis AG
NYSE:NVS
$292.82B
AstraZeneca PLC
NYSE:AZN
$278.78B
Novo Nordisk A/S
NYSE:NVO
$196.35B
Thermo Fisher Scientific Inc.
NYSE:TMO
$174.61B
Abbott Laboratories
NYSE:ABT
$152.98B
CVS Health Corporation
NYSE:CVS
$129.96B
Elevance Health Inc.
NYSE:ELV
$87.35B
Cigna Corporation
NYSE:CI
$78.87B
Humana Inc.
NYSE:HUM
$45.34B
SEC Filings
Recent regulatory filings
No filings found.
How much revenue does UNH generate?
UnitedHealth Group Incorporated (UNH) reported $447.57B of revenue in fiscal 2025.
Is UNH profitable?
UnitedHealth Group Incorporated (UNH) reported $12.06B of net income, with a net margin of 2.7%.
Explore More
Continue the stock analysis
Jump to another research area for this company.